Global Pharmaceutical Excipients Market Size & Trends Report Segmented by Product (Alcohols, Polymers, Others), Formulation (Oral, Topical, Parenteral, Others), Function (Fillers & Diluents, Coating Agents, Binders, Others) & Regional Forecast to 2030
The pharmaceutical excipients market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the increasing demand for innovative drug formulations, the rising prevalence of chronic diseases, and advancements in biopharmaceuticals. The growing interest in personalized medicine and the rise of generic drug production are further propelling the market’s expansion. However, stringent regulatory requirements and high costs associated with excipient development present notable challenges. To learn more about the research report, download a sample report.
Report Overview
Pharmaceutical excipients are inactive substances formulated alongside the active ingredient of a medication, serving to improve the drug's efficacy, stability, and usability. These substances, including binders, fillers, disintegrants, and lubricants, do not possess therapeutic activity but play a crucial role in ensuring the drug's desired action and delivery. They enhance solubility, protect active ingredients from degradation, and optimize the release of the medication in the body. Excipients are essential in modern pharmaceutical formulations and contribute significantly to advancements in drug delivery systems.
To learn more about the research report, download a sample report.
Rising Demand for Innovative Drug Delivery Systems
One of the pivotal factors propelling the market is the growing need for innovative drug delivery systems. Pharmaceutical companies are increasingly utilizing excipients to enable the formulation of drugs with controlled release, targeted delivery, and enhanced bioavailability. For instance, polymers and lipids are being extensively used in designing novel drug carriers like nanoparticles and liposomes. These excipients facilitate the precise release of therapeutic agents, enhancing patient compliance and treatment outcomes. The integration of excipients in such delivery systems supports the pharmaceutical industry's goals of reducing side effects and improving drug efficacy, making them indispensable in advancing healthcare solutions globally.
To learn more about the research report, download a sample report.
Increasing Use of Multifunctional Excipients
A significant advancement boosting the market is the adoption of multifunctional excipients. These compounds combine multiple properties, such as binding, disintegration, and stability enhancement, into a single ingredient. Multifunctional excipients simplify the formulation process, reduce manufacturing costs, and enhance drug performance. Recent developments in co-processed excipients, which blend two or more excipients to yield superior functionality, are gaining traction. For instance, combining microcrystalline cellulose with silicon dioxide can improve compressibility and flow properties. The industry is also witnessing innovations in excipients tailored for oral dissolvable and sustained-release tablets. This trend not only addresses cost-efficiency but also aligns with the evolving needs for complex drug formulations, positioning multifunctional excipients as a cornerstone of future pharmaceutical advancements.
Competitive Landscape Analysis
The global pharmaceutical excipients market is marked by the presence of established and emerging market players such as Eastman Chemical Corporation; P&G Chemicals; Avantor Performance Materials, LLC; Huntsman Corporation; BASF SE; Ashland Inc.; Evonik Industries AG; Roquette; Kerry Group Plc; Colorcon Inc.; Lubrizol Corporation; Merck KGaA and JRS Pharma among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 - 2024 |
|
Forecast Period |
2025 – 2030 |
|
Growth Rate |
6% |
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
Product, Formulation and Function |
|
Regional Scope |
|
|
Key Companies Mapped |
Eastman Chemical Corporation; P&G Chemicals; Avantor Performance Materials, LLC; Huntsman Corporation; BASF SE; Ashland Inc.; Evonik Industries AG; Roquette; Kerry Group Plc; Colorcon Inc.; Lubrizol Corporation; Merck KGaA and JRS Pharma |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global pharmaceutical excipients market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, formulation and function.
- Market Size & Forecast (2023-2030), By Product, USD Million
- Polymers
- Alcohols
- Sugar
- Minerals
- Gelatin
- Market Size & Forecast (2023-2030), By Formulation, USD Million
- Oral
- Topical
- Parenteral
- Others
- Market Size & Forecast (2023-2030), By Function, USD Million
- Fillers and Diluents
- Suspending & Viscosity Agents
- Coating Agents
- Binders
- Flavoring Agents & Sweeteners
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Others
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the pharmaceutical excipients market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the pharmaceutical excipients market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Pharmaceutical Excipients Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising demand for innovative drug delivery systems
- Growth in generic drug production
- Increased prevalence of chronic diseases
- Advancements in biopharmaceuticals
- Adoption of nanotechnology in drug formulation
- Restraints
- High cost of excipient development
- Stringent regulatory frameworks
- Complex manufacturing processes
- Opportunities
- Rising adoption of 3D printing in pharma
- Growing demand for personalized medicine formulation
- Expansion of the biopharmaceutical industry
- Emerging markets in Asia-Pacific
- Key Market Trends
- Increasing use of multifunctional excipients
- Shift toward sustainable excipient production
- Unmet Market Needs
- Industry Speaks
- Global Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Polymers
- Alcohols
- Sugar
- Minerals
- Gelatine
- Global Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Formulation, USD Million
- Introduction
- Oral
- Topical
- Parenteral
- Others
- Global Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Function, USD Million
- Introduction
- Fillers and Diluents
- Suspending & Viscosity Agents
- Coating Agents
- Binders
- Flavoring Agents & Sweeteners
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Others
- Global Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- US
- Europe Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- UK
- Asia Pacific (APAC) Pharmaceutical Excipients Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million))
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- China
- Latin America (LATAM) Pharmaceutical Excipients Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Middle East & Africa (MEA) Pharmaceutical Excipients Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Formulation (USD Million)
- Market Size & Forecast, By Function (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- Evonik Industries AG
- Roquette
- Kerry Group Plc
- Colorcon Inc.
- Lubrizol Corporation
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
